Many diseases, including ataxia telangiectasia (AT), chronic lymphocytic leukemia (CLL), and colorectal cancer (CRC) are associated with mutations in ATM28, 29, leaving ATR as the primary mediator of repair. Here, ATR is linked to B-cell chronic lymphocytic leukemia.